Catherine Stace

Catherine Stace is an accomplished professional with extensive experience in business development and technology application within the biotechnology and healthcare sectors. Currently serving as VP of Business Development (USA E) and Strategic Relationships at o2h discovery and as Executive Vice President at Kuano, Stace focuses on quantum and AI solutions for drug discovery. As the Founder and Director of Platform First Ltd, Stace applies Systems Engineering principles to enhance biotech platforms. Previous roles include Executive Vice President at Domainex and Head of Technology at XenoVida, where Stace developed healthcare platforms for comprehensive health analyses. Stace holds a PhD in Cell Biology from the University of Cambridge and an MBA from The Open University, supplemented by certifications in Systems Engineering.